High Rate of Spontaneous Negativity for Hepatitis C Virus RNA after Establishment of Chronic Infection in Alaska Natives
Departments of 1Medicine, Division of Allergy and Infectious Diseases, and 2Laboratory Medicine, Virology Division, University of Washington, Seattle, Washington; and 3Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, and 4Viral Hepatitis Program, Alaska Native Medical Center, Anchorage, Alaska
Background.
Hepatitis C virus (HCV) leads to chronic infection in 70%–85% of exposed patients. Spontaneous clearance of the virus after chronic infection is believed to occur rarely.
Methods.
Alaska Natives who tested positive for HCV antibodies were enrolled in a prospective study that began in 1994 and were followed up on a regular basis. Individuals who tested positive for HCV RNA on 3 separate dates, each of which were at least 1 year apart, were included. Being negative for the virus was defined as having at least 1 negative HCV RNA test result after chronic viremia had been established.
Results.
Of the 815 patients enrolled in the cohort, 139 met entry criteria and were observed for a mean period of 7.0 years. Eleven (8%) of the persons had at least 1 test in which HCV RNA was undetectable; 7 were classified as having either possible or probable clearance of the virus, corresponding to an annualized clearance rate of 0.74% per person‐year (95% CI, 0.30%–1.53%). Of 9 patients who underwent subsequent HCV RNA testing, 5 (56%) had negative test results. A low HCV RNA level was significantly associated with spontaneous nondetectability of HCV RNA.
Conclusion.
Spontaneous HCV RNA negativity during chronic HCV infection is a surprisingly frequent event and is associated with low HCV RNA titers. Knowledge of immunologic determinants of clearance may open up avenues of novel therapy.
Received 13 September 2005; accepted 18 November 2005; electronically published 28 February 2006.
-
(See the editorial commentary by Lauer and Kim on pages 953–4)
Cited by
Online publication date: 1-May-2009.
CrossRef
Online publication date: 1-Oct-2008.
CrossRef
Online publication date: 1-Dec-2007.
CrossRef
Online publication date: 1-Apr-2007.
CrossRef
Online publication date: 1-Apr-2006.
-
Presented in part: 41st Annual Meeting of the Infectious Disease Society of America, San Diego, CA, October 2003 (poster 588).



